Erlotinib Active Not Recruiting Phase 1 Trials for Cancers / Lung Cancer Non-Small Cell Cancer (NSCLC) Diagnostic

IndicationsStatusPurposePhase
Active Not RecruitingDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT00708448Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients